The University of Southampton
University of Southampton Institutional Repository

Tolerance and tachyphylaxis to medications for attention-deficit/hyperactivity disorder (ADHD): a systematic review of empirical studies

Tolerance and tachyphylaxis to medications for attention-deficit/hyperactivity disorder (ADHD): a systematic review of empirical studies
Tolerance and tachyphylaxis to medications for attention-deficit/hyperactivity disorder (ADHD): a systematic review of empirical studies
Background and objectives: individuals with Attention-Deficit/Hyperactivity Disorder (ADHD), their families, and clinicians may report worsening symptoms despite compliant use of medication, suggesting potential tolerance, but evidence remains conflicting. Some studies have also suggested tachyphylaxis, or acute tolerance, though research is limited. We conducted the first systematic review of empirical studies focussing on tolerance/tachyphylaxis to ADHD medication to clarify their potential clinical relevance.

Methods: as registered on PROSPERO (CRD42024594759), we searched Pubmed, OVID, (Including Psychinfo and Medline) and Web of Knowledge up to 1 September 2024, and assessed the risk of bias using NIH Quality Assessment tools.
Results: The identified 17 studies were either interventional or observational, and varied greatly in design and duration. Four investigated tachyphylaxis, 9 tolerance to the subjective and behavioural effects, and 4 tolerance to cardiovascular effects. We found preliminary evidence of tachyphylaxis to the affective or behavioural effects of stimulants, as well as tolerance to the subjective effects of d-amphetamine, such as drug liking and excitation, in neurotypical volunteers in the short-term. Conversely, there was little or no evidence for tolerance to the therapeutic or cardiovascular effects of ADHD medication in clinical settings in the longer-term. Quality was rated as low in most studies due to small sample sizes and methodological limitations.

Conclusion: overall, these results do not support the hypothesis that tolerance commonly develops to the therapeutic effects of ADHD medication, although robustly designed longitudinal studies are needed to provide more conclusive evidence. Clinicians may consider other potential explanations for reduced therapeutic effects over time, including natural fluctuations of symptoms, limited compliance, life events, and co-occurrent mental health conditions.
1172-7047
Smith, Chris
f0f99916-f095-4bc8-bf00-ed45448c0a8e
Walker, Hollie
93d25c58-e03a-412c-b3b0-744dccba1ff3
Parlatini, Valeria
6cdfb200-40ce-43ce-84da-dcb6eba0f67a
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Smith, Chris
f0f99916-f095-4bc8-bf00-ed45448c0a8e
Walker, Hollie
93d25c58-e03a-412c-b3b0-744dccba1ff3
Parlatini, Valeria
6cdfb200-40ce-43ce-84da-dcb6eba0f67a
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb

Smith, Chris, Walker, Hollie, Parlatini, Valeria and Cortese, Samuele (2025) Tolerance and tachyphylaxis to medications for attention-deficit/hyperactivity disorder (ADHD): a systematic review of empirical studies. CNS drugs. (In Press)

Record type: Article

Abstract

Background and objectives: individuals with Attention-Deficit/Hyperactivity Disorder (ADHD), their families, and clinicians may report worsening symptoms despite compliant use of medication, suggesting potential tolerance, but evidence remains conflicting. Some studies have also suggested tachyphylaxis, or acute tolerance, though research is limited. We conducted the first systematic review of empirical studies focussing on tolerance/tachyphylaxis to ADHD medication to clarify their potential clinical relevance.

Methods: as registered on PROSPERO (CRD42024594759), we searched Pubmed, OVID, (Including Psychinfo and Medline) and Web of Knowledge up to 1 September 2024, and assessed the risk of bias using NIH Quality Assessment tools.
Results: The identified 17 studies were either interventional or observational, and varied greatly in design and duration. Four investigated tachyphylaxis, 9 tolerance to the subjective and behavioural effects, and 4 tolerance to cardiovascular effects. We found preliminary evidence of tachyphylaxis to the affective or behavioural effects of stimulants, as well as tolerance to the subjective effects of d-amphetamine, such as drug liking and excitation, in neurotypical volunteers in the short-term. Conversely, there was little or no evidence for tolerance to the therapeutic or cardiovascular effects of ADHD medication in clinical settings in the longer-term. Quality was rated as low in most studies due to small sample sizes and methodological limitations.

Conclusion: overall, these results do not support the hypothesis that tolerance commonly develops to the therapeutic effects of ADHD medication, although robustly designed longitudinal studies are needed to provide more conclusive evidence. Clinicians may consider other potential explanations for reduced therapeutic effects over time, including natural fluctuations of symptoms, limited compliance, life events, and co-occurrent mental health conditions.

Text
Full Systematic Review_ref_v_cleaned_v3_cleaned - Accepted Manuscript
Restricted to Repository staff only until 17 December 2026.
Available under License Other.
Request a copy

More information

Accepted/In Press date: 17 December 2025

Identifiers

Local EPrints ID: 508722
URI: http://eprints.soton.ac.uk/id/eprint/508722
ISSN: 1172-7047
PURE UUID: 7321f64f-a273-4e99-a3df-216ca13cd765
ORCID for Valeria Parlatini: ORCID iD orcid.org/0000-0002-4754-2494
ORCID for Samuele Cortese: ORCID iD orcid.org/0000-0001-5877-8075

Catalogue record

Date deposited: 02 Feb 2026 17:40
Last modified: 03 Feb 2026 03:10

Export record

Contributors

Author: Chris Smith
Author: Hollie Walker
Author: Valeria Parlatini ORCID iD
Author: Samuele Cortese ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×